PIK3CA and breast cancer: KM survival analysis indicated that neither PIK3CA mutation status (Fig. S4A–C), nor mutation regions (Fig. S4D–F) could accurately stratify BC patients, which also confirmed the greater prognostic value of the PDIS compared to PIK3CA mutation alone.